178 related articles for article (PubMed ID: 31754973)
1. RASSF1A-Hippo pathway link in patients with urothelial carcinoma of bladder: plausible therapeutic target.
Khandelwal M; Anand V; Appunni S; Seth A; Singh P; Mathur S; Sharma A
Mol Cell Biochem; 2020 Jan; 464(1-2):51-63. PubMed ID: 31754973
[TBL] [Abstract][Full Text] [Related]
2. Decitabine augments cytotoxicity of cisplatin and doxorubicin to bladder cancer cells by activating hippo pathway through RASSF1A.
Khandelwal M; Anand V; Appunni S; Seth A; Singh P; Mathur S; Sharma A
Mol Cell Biochem; 2018 Sep; 446(1-2):105-114. PubMed ID: 29368096
[TBL] [Abstract][Full Text] [Related]
3. RASSF1A-mediated regulation of AREG via the Hippo pathway in hepatocellular carcinoma.
Ahn EY; Kim JS; Kim GJ; Park YN
Mol Cancer Res; 2013 Jul; 11(7):748-58. PubMed ID: 23594797
[TBL] [Abstract][Full Text] [Related]
4. CD44 acts through RhoA to regulate YAP signaling.
Zhang Y; Xia H; Ge X; Chen Q; Yuan D; Chen Q; Leng W; Chen L; Tang Q; Bi F
Cell Signal; 2014 Nov; 26(11):2504-13. PubMed ID: 25101858
[TBL] [Abstract][Full Text] [Related]
5. Actin cytoskeleton regulates Hippo signaling.
Reddy P; Deguchi M; Cheng Y; Hsueh AJ
PLoS One; 2013; 8(9):e73763. PubMed ID: 24040060
[TBL] [Abstract][Full Text] [Related]
6. ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling.
Liu Y; Su P; Zhao W; Li X; Yang X; Fan J; Yang H; Yan C; Mao L; Ding Y; Zhu J; Niu Z; Zhuang T
Cancer Sci; 2021 Jul; 112(7):2714-2727. PubMed ID: 33939216
[TBL] [Abstract][Full Text] [Related]
7. [Doublecortin-like kinase 1 activates Hippo pathway to promote migration, invasion and proliferation of pancreatic cancer cells].
Yan R; Liang ZW; Liu HS; Ge Y; An GY
Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):594-604. PubMed ID: 37462016
[No Abstract] [Full Text] [Related]
8. YAP Subcellular Localization and Hippo Pathway Transcriptome Analysis in Pediatric Hepatocellular Carcinoma.
LaQuaglia MJ; Grijalva JL; Mueller KA; Perez-Atayde AR; Kim HB; Sadri-Vakili G; Vakili K
Sci Rep; 2016 Sep; 6():30238. PubMed ID: 27605415
[TBL] [Abstract][Full Text] [Related]
9. Cell-intrinsic PD-1 promotes proliferation in pancreatic cancer by targeting CYR61/CTGF via the hippo pathway.
Pu N; Gao S; Yin H; Li JA; Wu W; Fang Y; Zhang L; Rong Y; Xu X; Wang D; Kuang T; Jin D; Yu J; Lou W
Cancer Lett; 2019 Sep; 460():42-53. PubMed ID: 31233838
[TBL] [Abstract][Full Text] [Related]
10. Taxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF.
Lai D; Ho KC; Hao Y; Yang X
Cancer Res; 2011 Apr; 71(7):2728-38. PubMed ID: 21349946
[TBL] [Abstract][Full Text] [Related]
11. Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer.
Chen PP; Li WJ; Wang Y; Zhao S; Li DY; Feng LY; Shi XL; Koeffler HP; Tong XJ; Xie D
PLoS One; 2007 Jun; 2(6):e534. PubMed ID: 17579708
[TBL] [Abstract][Full Text] [Related]
12. Rheb may complex with RASSF1A to coordinate Hippo and TOR signaling.
Nelson N; Clark GJ
Oncotarget; 2016 Jun; 7(23):33821-31. PubMed ID: 27034171
[TBL] [Abstract][Full Text] [Related]
13. Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma.
Zhou ZQ; Cao WH; Xie JJ; Lin J; Shen ZY; Zhang QY; Shen JH; Xu LY; Li EM
BMC Cancer; 2009 Aug; 9():291. PubMed ID: 19698122
[TBL] [Abstract][Full Text] [Related]
14. Salvador protein is a tumor suppressor effector of RASSF1A with hippo pathway-independent functions.
Donninger H; Allen N; Henson A; Pogue J; Williams A; Gordon L; Kassler S; Dunwell T; Latif F; Clark GJ
J Biol Chem; 2011 May; 286(21):18483-91. PubMed ID: 21489991
[TBL] [Abstract][Full Text] [Related]
15. The HIPPO Transducer YAP and Its Targets CTGF and Cyr61 Drive a Paracrine Signalling in Cold Atmospheric Plasma-Mediated Wound Healing.
Shome D; von Woedtke T; Riedel K; Masur K
Oxid Med Cell Longev; 2020; 2020():4910280. PubMed ID: 32104533
[TBL] [Abstract][Full Text] [Related]
16. Activating Hippo Pathway via Rassf1 by Ursolic Acid Suppresses the Tumorigenesis of Gastric Cancer.
Kim SH; Jin H; Meng RY; Kim DY; Liu YC; Chai OH; Park BH; Kim SM
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547587
[TBL] [Abstract][Full Text] [Related]
17. TGF-β Targets the Hippo Pathway Scaffold RASSF1A to Facilitate YAP/SMAD2 Nuclear Translocation.
Pefani DE; Pankova D; Abraham AG; Grawenda AM; Vlahov N; Scrace S; O' Neill E
Mol Cell; 2016 Jul; 63(1):156-66. PubMed ID: 27292796
[TBL] [Abstract][Full Text] [Related]
18. YAP, CTGF and Cyr61 are overexpressed in tamoxifen-resistant breast cancer and induce transcriptional repression of ERα.
Kim H; Son S; Ko Y; Lee JE; Kim S; Shin I
J Cell Sci; 2021 Jun; 134(11):. PubMed ID: 34096606
[TBL] [Abstract][Full Text] [Related]
19. Atheroprotective laminar flow inhibits Hippo pathway effector YAP in endothelial cells.
Xu S; Koroleva M; Yin M; Jin ZG
Transl Res; 2016 Oct; 176():18-28.e2. PubMed ID: 27295628
[TBL] [Abstract][Full Text] [Related]
20. WBP2 promotes gastric cancer cell migration via novel targeting of LATS2 kinase in the Hippo tumor suppressor pathway.
Hum M; Tan HJ; Yang Y; Srivastava S; Teh M; Lim YP
FASEB J; 2021 Feb; 35(2):e21290. PubMed ID: 33475198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
